Thermo Fisher Scientific Analytical Instruments — Restructuring and other costs increased by 5300.0% to $54.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 5300.0%, from $1.00M to $54.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
High costs may signal a major operational pivot or efficiency drive, while low costs suggest a stable, mature operating environment.
Costs incurred to reorganize, consolidate, or streamline the operations of the Analytical Instruments segment. These are...
Commonly reported by large industrial and scientific firms undergoing periodic operational optimization.
tmo_segment_analytical_instruments_restructuring_and_other_costs| Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00M | $2.00M | $8.25M | $8.25M | $8.25M | $8.25M | $1.00M | $1.00M | $1.00M | $1.00M | $54.00M |
| QoQ Change | — | +0.0% | +312.5% | +0.0% | +0.0% | +0.0% | -87.9% | +0.0% | +0.0% | +0.0% | >999% |
| YoY Change | — | — | +312.5% | +312.5% | — | — | -87.9% | -87.9% | -87.9% | -87.9% | >999% |
We use cookies for analytics. See our Privacy and Cookie Policy.